Crizotinib-radiation therapy combination may help preserve hearing in NF2
Adding the targeted cancer therapy drug crizotinib to radiation therapy…
6 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Adding the targeted cancer therapy drug crizotinib to radiation therapy for tumours associated with the genetic disorder neurofibromatosis 2 may reduce the hearing damage that can be exacerbated by radiotherapy...
Follow: